Rachel W. Humphrey
Overview
Rachel W. Humphrey received an average of $3M in total compensation, including $261K in salary, at CytomX Therapeutics between 2015 and 2016.
Source: SEC filing on May 9, 2017.
Related executives
We found nine more executives who work or worked at CytomX Therapeutics.
Sean McCarthy
CytomX Therapeutics
Chief Executive Officer
Marcia Belvin
CytomX Therapeutics
Chief Scientific Officer
Jeff Landau
CytomX Therapeutics
Senior Vice President and Chief Business Officer
Amy Peterson
CytomX Therapeutics
Chief Operating Officer
Carlos Campoy
CytomX Therapeutics
Chief Financial Officer
Lloyd Rowland
CytomX Therapeutics
Senior Vice President,
Alison Hannah
CytomX Therapeutics
Chief Medical Officer
W Kavanaugh
CytomX Therapeutics